Status:
COMPLETED
White Reflective Drape in Phototherapy for Neonatal Hyperbilirubinemia
Lead Sponsor:
Saglik Bilimleri Universitesi
Conditions:
Neonatal Hyperbilirubinemia
Eligibility:
All Genders
Up to 28 years
Phase:
NA
Brief Summary
This randomized controlled trial investigated the effect of using a white reflective drape during phototherapy on serum bilirubin levels and hospital stay in neonates diagnosed with hyperbilirubinemia...
Detailed Description
Neonatal hyperbilirubinemia is one of the most common conditions in the neonatal period and may lead to severe complications if untreated. Phototherapy is the standard treatment; however, its effectiv...
Eligibility Criteria
Inclusion
- Gestational age ≥ 34 weeks
- Diagnosed with hyperbilirubinemia
- Physician decision to initiate phototherapy Written informed consent obtained from parents
Exclusion
- Critical illness (e.g., ECMO, nitric oxide therapy)
- Congenital anomalies
- Blood group incompatibility or positive Coombs test
- Bilirubin level at exchange transfusion threshold
Key Trial Info
Start Date :
October 1 2023
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
August 18 2024
Estimated Enrollment :
102 Patients enrolled
Trial Details
Trial ID
NCT07156721
Start Date
October 1 2023
End Date
August 18 2024
Last Update
September 15 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Gazi University Hospital, Neonatal Intensive Care Unit
Ankara, Turkey (Türkiye)